regeneron's science chief on starting clinical trials for covid-19 antibody drug
Published 4 years ago • 7.3K plays • Length 5:32Download video MP4
Download video MP3
Similar videos
-
10:39
regeneron science chief to begin testing coronavirus antibody treatment this summer
-
3:19
regeneron aims for covid-19 drug trials by early summer
-
1:22
regeneron reports positive results on initial data for covid-19 antibody drug
-
1:08
regeneron receives $450 million federal contract for covid-19 antibody drug
-
3:11
regeneron chief scientist explains promising results for covid-19 antibody cocktail
-
7:06
regeneron ceo: we want to retain efficacy and eliminate bad side effects with our cancer treatments
-
5:49
building a biotech | forbes
-
7:38
regeneron ceo on coronavirus drug timeline
-
2:32
regeneron covid-19 'antibody cocktail' drug enters late-stage trials
-
2:17
regeneron's antibody drug offers strong protection against covid-19
-
6:58
regeneron co-founder on the race for a coronavirus treatment
-
4:17
regeneron reports antibody drug lowers risk of medical visits by 57%
-
3:53
regeneron president on covid antibody cocktail efficacy and supply chain
-
4:45
regeneron ceo on teaming up with roche to develop covid-19 antibody cocktail
-
2:02
regeneron's antibody drug likely to be in short supply because it's grown in live cells
-
2:01
regeneron's antibody drug reduces risk of death in some covid patients
-
2:47
regeneron launches us clinical trials to treat severe covid-19 symptoms
-
4:29
why regeneron's antibody drug will be in short supply
-
2:55
regeneron ceo on distribution of covid-19 antibody cocktail
-
1:59
significance of regeneron antibody cocktail: former fda chief scott gottlieb
-
9:08
regeneron begins covid-19 antibody therapy testing
-
2:40
coronavirus: developing a therapy for preventing and fighting the outbreak, regeneron says